BELLEROPHON THERAPEUTICS INC (BLPH) Stock Analyst Ratings
USA - NASDAQ:BLPH - US0787713009 - Common Stock
0.1025 USD
-0.28 (-73.39%)
0.114 USD
+0.01 (+11.22%)
ChartMill assigns a Buy % Consensus number of 43% to BLPH. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 2.04. This target is 1890.24% above the current price.
BLPH was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about BLPH.
In the previous month the buy percentage consensus was at a similar level.
BLPH was analyzed by 6 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-06-06 | Laidlaw & Co. | Downgrade | Buy -> Hold |
| 2023-06-06 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-05-17 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-09 | Laidlaw & Co. | Initiate | Buy |
| 2023-04-04 | HC Wainwright & Co. | Reiterate | Buy |
BELLEROPHON THERAPEUTICS INC / BLPH FAQ
What is the average price target for BELLEROPHON THERAPEUTICS INC (BLPH) stock?
6 analysts have analysed BLPH and the average price target is 2.04 USD. This implies a price increase of 1890.24% is expected in the next year compared to the current price of 0.1025.
What is the consensus rating for BELLEROPHON THERAPEUTICS INC (BLPH) stock?
The consensus rating for BELLEROPHON THERAPEUTICS INC (BLPH) is 43.3333 / 100 . This indicates that analysts generally have a neutral outlook on the stock.